NANA AKUA DWOMO: Open Payments
NPI 1457502502 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 43 payments from 19 companies in 2025. Trend: 2023 $1,651 · 2024 $912 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $147 |
| Sumitomo Pharma America, Inc. | 6 | $103 |
| Lundbeck LLC | 5 | $84 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: VRAYLAR, GEMTESA, REXULTI, KEVEYIS, INGREZZA, AIRSUPRA, Kerendia, CAPLYTA.
Industry payments across OH — which companies pay providers there.
